Graves’ Ophthalmopathy – Pipeline Review, H1 2016 Featuring Genmab, Neothetics, Novartis & Yuhan – Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Graves' Ophthalmopathy - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Graves' Ophthalmopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.